Biocon

• Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial

  Consulting or advice, Fees or honoraria, Grants or research support, 13 Aug 2026

• Growth differentiation factor 15 and the risk of hip fracture in older adults

  Consulting or advice, Grants or research support, 28 Feb 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Twenty-Five Years Longitudinal Real-World Analysis of Statin Therapy Outcomes in People with Diabetes on Telemedicine Follow-up and Predictors of Cardiovascular Events

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025